DiaMedica Therapeutics Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2022 | $-3.9M | $-3.9M | $0 | $308.0K |
| Jun 2022 | $-2.5M | $-2.5M | $6.0K | $365.0K |
| Sep 2022 | $-2.4M | $-2.4M | $43.0K | $418.0K |
| Dec 2022 | $-2.8M | $-2.8M | $32.0K | $411.0K |
| Mar 2023 | $-5.1M | $-5.1M | $7.0K | $422.0K |
| Jun 2023 | $-5.0M | $-5.0M | $4.0K | $380.0K |
| Sep 2023 | $-4.8M | $-4.8M | $10.0K | $425.0K |
| Dec 2023 | $-3.8M | $-3.8M | $3.0K | $456.0K |
| Mar 2024 | $-6.7M | $-6.7M | $9.0K | $488.0K |
| Jun 2024 | $-4.5M | $-4.5M | $0 | $443.0K |
| Sep 2024 | $-4.5M | $-4.5M | $9.0K | $565.0K |
| Dec 2024 | $-6.4M | $-6.4M | $7.0K | $589.0K |
| Mar 2025 | $-7.1M | $-7.2M | $12.0K | $867.0K |
| Jun 2025 | $-7.6M | $-7.6M | $6.0K | $771.0K |
| Sep 2025 | $-6.6M | $-6.6M | $16.0K | $1.0M |
| Dec 2025 | $-7.8M | $-7.8M | $6.0K | $1.2M |
| Mar 2026 | $-9.1M | $-9.1M | $8.0K | $822.0K |
| Jun 2026 | $-8.1M | $-8.1M | $3.0K | $1.1M |